Search Breastcancer.org

Search results

• Sort By Date
• Sort By Relevance

Good news for lymphedema patients?

Last modified on August 25, 2008

Question from MsMadelyn: Reading this could leave someone facing lymphedema (or its possibility) feeling a little hopeless and helpless. So is there any good news about improvements in the future through research or improved methods? Answers — Kathryn Schmitz, Ph.D., M.P.H., F.A.C.S.M.: There's already been good news. The first good news…

July 2006 Research News

Last modified on January 29, 2010

Raloxifene As Effective As Tamoxifen in Reducing Risk of Invasive Breast Cancer Results show that raloxifene was as effective as tamoxifen in reducing the risk of breast cancer in post-menopausal women at increased risk, but with no personal history of the disease. Read more. Raloxifene and Tamoxifen Offer Similar Quality of Life STAR trial results…

Latest news on Tykerb for metastases?

Last modified on November 20, 2008

Question from KF: What is the latest news about Tykerb for metastatic breast cancer treatment, especially for brain metastasis? Will it likely be given in addition to (especially if Herceptin is still working in the rest of the patient's body) or instead of Herceptin (if/when brain metastasis occurs)? Is there other info or online references about…

Research News on Reconstruction

Last modified on July 10, 2008

these studies in easy-to-understand language, explaining what the results might mean for YOU. If you'd like to find out about upcoming Research News reports, as well as other important Breastcancer.org programs, including Ask-the-Expert Online Conferences, we encourage you to sign up for . If you find the Research News articles at Breastcancer.org helpful…

February 2006 Research News

Last modified on January 27, 2010

Slows Advanced Breast Cancer If you're looking for promising new medicines that can work well with chemotherapy, you might want to read this article. Read more… The February 2006 Research News section was made possible by an unrestricted educational grant from Genentech BioOncology.…

Most encouraging news from the conference?

Last modified on January 05, 2010

Question from rebecca: What was the most encouraging news you heard at the San Antonio conference this year? Answer — Kathy Miller, M.D.: I think it was the Phase III trial comparing denosumab to Zometa in women with metastatic disease involving the bones. This is an important and common problem for women with metastatic disease. Denosumab…

Receptor-negative adjuvant treatment news?

Last modified on November 20, 2008

Question from Adrian: Any news regarding adjuvant treatment for receptor-negative breast cancer? Anything expected in near future? Answer — Jennifer Griggs, M.D., M.P.H.: We've pointed out before on this website that most of the treatments with chemotherapy and most of the changes in how we give chemotherapy benefit people with estrogen…

Research News

Last modified on January 11, 2010

Our experts routinely examine breast cancer research for important advances, updates, and changes in how breast cancer is treated and diagnosed. Breastcancer.org strives to bring you updates on the latest breast cancer research through its Research News program. Medical experts at Breastcancer.org provide easy-to-understand summaries of what…

Big, positive news presented at ASCO?

Last modified on August 20, 2008

Question from Marcello: Doctors, overall did you take away a general sense of positive news and advances from this ASCO meeting, whether the changes and improvements were big or small? Answers — Carol Kaplan, M.D.: Absolutely. We are excitingly moving into an era of treating patients in a more targeted manner. Breast cancer research…

August 2006 Research News

Last modified on January 29, 2010

Gaining Weight after Menopause Seems to Increase Breast Cancer Risk in Post-Menopausal Women This offers more evidence that extra weight throughout your adult life (after age 18) can increase breast cancer risk. This also was found to be true for women who gained weight after menopause. Read more… AlloDerm Appears to Offer Good Reconstruction Resul…